Qube Research & Technologies (QRT)’s Disc Medicine IRON Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$933K	Buy	+12,758	New	+$877K	﹤0.01%	2436
2024 Q2	–	Sell	-74,777	Closed	-$4.66M	–	4268
2024 Q1	$4.66M	Buy	74,777 +24,066	+47%	+$1.56M	0.01%	1275
2023 Q4	$2.93M	Buy	+50,711	New	+$2.6M	0.01%	1334
2022 Q4	–	Sell	-549	Closed	-$27K	–	2732
2022 Q3	$27K	Sell	549 -71	-11%	-$3.35K	﹤0.01%	2254
2022 Q2	$31K	Buy	+620	New	+$27.4K	﹤0.01%	2204

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s IRON Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Disc Medicine (IRON) in Q2 2026: 12,758 shares worth $933K. The stake represents ﹤0.01% of the portfolio and ranks #2436 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IRON as recently as Q1 2024.

Qube Research & Technologies (QRT) first reported a position in IRON in Q2 2022 and has held it in 5 quarters since. The position peaked at $4.66M in Q1 2024. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Qube Research & Technologies (QRT) held 12,758 shares of Disc Medicine worth $933K as of Q2 2026.
Disc Medicine was a new Qube Research & Technologies (QRT) position in Q2 2026.
Disc Medicine made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2436 holding.
Qube Research & Technologies (QRT) first reported a position in Disc Medicine in Q2 2022 and has held it in 5 quarters since.
Qube Research & Technologies (QRT)'s Disc Medicine position peaked at $4.66M in Q1 2024.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.